EQS-News: Immunic, Inc.: Immunic Reports Positive Interim Da

EQS-News: Immunic, Inc.: Immunic Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis

EQS-News: Immunic, Inc.: Immunic Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Ukraine , Russia , United States , Switzerland , America , Edna Kaplan , Daniel Vitt , Jens Kuhle , Jessica Breu , Neuroprotective Potential , Andreas Muehler , Paula Schwartz , Distribution Services , Nasdaq , Immunic Inc , Sclerosis Centre , Rx Communications Group , Program In Relapsing Multiple Sclerosis Ongoing , University Hospital Basel , Exchange Commission , Reports Positive Interim Data , Vidofludimus Calcium , Progressive Multiple Sclerosis , Week Data , First Half , Patients Shows Improvements , Biomarker Nfl , Consistent Throughout , Overall Progressive Multiple Sclerosis Population , All Subtypes , Volume Data , Cohort Expected , Relapsing Multiple Sclerosis Ongoing , Held Tomorrow , Senior Physician , Neuroimmunology Unit , Multiple Sclerosis Centre , Chief Executive Officer , Chief Medical Officer , North America , Private Securities Litigation Reform Act , Annual Report , Investor Relations , Corporate News , Regulatory Announcements , Aktien Sie ,